University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: Columbia Pharmacy, Chicago, IL
Amount: An estimated $900,000
An estimated start date of 5/16/2019 through 6/30/2020
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Monday, May 20, 2019
The University awarded a contract for Intravenous Immune Globulin.
Intravenous Immune Globulin (IVIG) - IVIG is therapeutically essential for transplant, pediatric, and neurology patients among others. A significant portion of IVIG use is for transplant patients as part of their immunomodulation therapy.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) There is a national shortage of IVIG, the manufacturer of the product we use is no longer making it available in the U.S., other companies that produce IVIG are not taking new customers, and we use 1000 grams per month in the hospital on a variety of patients. There is no substitute drug product for patients who need IVIG.
For additional information, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.